We have collected information about Liposomes For Intravitreal Drug Delivery A State Of The Art for you. Follow the links to find out details on Liposomes For Intravitreal Drug Delivery A State Of The Art.
https://www.sciencedirect.com/science/article/pii/S0168365912000247
Jul 20, 2012 · Intraocular drug delivery using liposomes may be influenced by a variety of factors including the liposome-drug half-life within the eye, the stability of the liposome, the adherence of the liposome to the various ocular surfaces, the passage of the liposome across tissue barriers such as the internal limiting membrane (ILM) of the retina and finally the disease state.Author: Amélie Bochot, Elias Fattal
https://www.researchgate.net/publication/221790915_Liposomes_for_intravitreal_drug_delivery_A_state_of_the_art
Liposomes are the class of drug delivery systems which are considered as biodegradable, biocompatible, flexible, non-ionic and non-toxic and provides direct interaction of …
https://www.academia.edu/15068509/Liposomes_for_intravitreal_drug_delivery_A_state_of_the_art
(PDF) Liposomes for intravitreal drug delivery: A state of the art Amélie Bochot - Academia.edu Intravitreal administration of drugs has raised a large interest during the last two decades improving the treatment of infectious diseases of the posterior segment of the eye or edematous maculopathies. This route of administration allows achieving
https://www.liebertpub.com/doi/10.1089/jop.2000.16.511
Liposomes for intravitreal drug delivery: A state of the art Journal of Controlled Release, Vol. 161, No. 2 Edaravone-loaded liposomes for retinal protection against oxidative stress-induced retinal damage European Journal of Pharmaceutics and Biopharmaceutics, Vol. 79, No. 1Author: S.K. Gupta, T. Velpandian, N. Dhingra, J. Jaiswal
https://www.tandfonline.com/doi/abs/10.1080/1061186X.2019.1648479
In recent times, a great deal of efforts has been made to modify the surface of liposomes with ligands for the purpose of achieving targeted drug delivery. Due to the morphology of liposomes, their surfaces can be engineered by attaching molecules such as oligosaccharides, peptides, antibodies, antigens and oligonucleotides to the bilayer structure.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4172103/
Sep 16, 2014 · Thermosensitive liposomes for MRI-guided drug delivery. MRI is the method of choice for image-guided drug delivery with TSL. Its abilities with regard to morphological and functional tumor characterization without exposure to ionizing radiation are well known, and it is a standard method in clinical use.Author: Barbara Kneidl, Michael Peller, Gerhard Winter, Lars H Lindner, Martin Hossann
http://jpet.aspetjournals.org/content/early/2019/05/09/jpet.119.256933
Jan 01, 2019 · Parallel efforts for ocular drug delivery technologies for back of the eye disorders have resulted in the approval of various intravitreal implants. Novel drug delivery technologies including nanoparticles, nanomicelles, dendrimers, microneedles, liposomes and nanowafers are increasingly studied for anterior and posterior disorders.Author: Vrinda Gote, Sadia Sikder, Jeff Sicotte, Dhananjay Pal
https://www.mdpi.com/1999-4923/11/9/460/pdf
emulsions, implants, liposomes, nanomicelles, nanoparticles, ointments, suspensions, and many others forward described. The current review aims to make available a vast array of the patented available systems for therapeutics of ophthalmic illnesses [9]. 2. Drug Delivery Systems …Author: Eliana B. Souto, João Dias-Ferreira, Ana López-Machado, Miren Ettcheto, Amanda Cano, Antonio Camins ...
https://www.researchgate.net/publication/233400659_Preparation_Characterization_and_Applications_of_Liposomes_State_of_the_Art
Liposomes are safe carrier in delivery system and have been widely exploited due to their unique characteristics, such as high biocompatibility, biodegradability, and non-immunogenicity (12 ...
https://www.sciencedirect.com/science/article/pii/S0378517319308129
Clinically used intravitreal anti-VEGF antibodies are simple solutions with excipients. For that reason, patients require to undergo intravitreal injections every one or two months. Therefore, sustained drug delivery of these drugs is highly attractive, but also presents a great challenge.Author: Andrea Luaces-Rodríguez, Andrea Luaces-Rodríguez, Cristina Mondelo-García, Irene Zarra-Ferro, Miguel...
Searching for Liposomes For Intravitreal Drug Delivery A State Of The Art?
You can just click the links above. The data is collected for you.
